Meprobamate Tablet
Product Images NDC 69097-975

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Meprobamate (NDC 69097-975). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Meprobamate 01)

FDA Label Image

200-100 (Meprobamate 02)

This is a description of a medication called Meprobamate. It comes in the form of tablets with 100 tablets per bottle. Each tablet contains 200 mg of Meprabamate USP. Dosage information can be found in the package insert along with full prescribing information. These tablets come in a child-resistant container and should be stored at 20°-25°C. This medication is manufactured by IvaGen Phamaceuticals, Inc. which is a subsidiary of Cipla Lick. It is sold by Cipla USA, Inc. and can be found at their location in Warren, NJ.*

FDA Label Image

400-100 (Meprobamate 03)

This is a description of a medication called Meprobamate manufactured by InvaGen Pharmaceutical, a subsidiary of Cipla. It is a tablet that contains 400 mg of Maprobamate USP, and the dosage information can be found on the package insert. It should be kept in a well-closed container with a child-resistant closure and stored at a temperature between 20-25°C. It is dispensed by prescription only.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.